Further characterisation of proteolytic Clostridium botulinum type A5 reveals that neurotoxin formation is unaffected by loss of the CntR (BotR) promoter sigma factor binding site

Carter A. T., Mason D. R., Grant K. A., Franciosa G., Aureli P., Peck M. W.. (2010)

Journal of Clinical Microbiology, 48, 1012-1013


Journal of Clinical Microbiology, 48, 1012-1013


View Publication